Yaffe Award

The Sumner J. Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics

Theย Sumner J. Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeuticsย is given annually in recognition of significant and sustained contributions toward the improvement of children’s health through the expansion of the field of pediatric pharmacology and therapeutics. The Yaffe Award was established by the PPA Board of Directors in 2002.

Dr. Yaffe is aย founding fatherย of developmental and pediatric pharmacology and has influenced the fieldย throughout his entire career.

Recipients of the Yaffe Award give the Yaffe Award Lecture during the Annual Meeting each year.

โ€‹The Yaffe Committee is composed of senior members of the profession including past Presidents of PPA and past recipients of the Yaffe Award.

Any PPA member or Yaffe Award Committee member may nominate a person for the Yaffe Award. The nominee for the award does not need to be a PPA member. The nominator should submit a letter describing the most important achievements of the nominee and explaining why the nominee meets the criteria for the award along with a current CV from the nominee.

ABOUT SUMNER J. YAFFE
May 9, 1923 – August 10, 2011

Please readย In Memoriam: Sumner J. Yaffe, The Father of Pediatric Pharmacologyย written by George Giaicoia, MD and Michael Reed, PharmD. (J Pediatric Pharmacol Ther 2011;16(3):162-166)

By Stephen P. Spielberg, MD, PhD (written in 2003)

Dr. Sumner J. Yaffe was born in Boston, graduated from Boston Latin School, and Harvard College (with an interruption during World War II to serve in the Armed Forces). He received his BA in chemistry, then pursued an MA in Pharmacology at Harvard, and finally his MD from the University of Vermont. He returned to Harvard to complete his pediatric training at Children’s Hospital in Boston. After a Fulbright Scholarship at St. Mary’s Hospital in London, and a fellowship in metabolism at Harvard, he joined the faculty at Stanford University as Director of the Clinical Research Center for Premature Infants. It is here that his interest in neonatal pharmacology grew. In 1963, he moved to SUNY Buffalo as Professor of Pediatrics and Adjunct Professor of Biochemical Pharmacology. In 1975, he moved to the Children’s Hospital of Philadelphia to establish the first Division of Pediatric Clinical Pharmacology. During his distinguished academic career, he published upwards of 300 scientific articles and books dealing with a wide range of developmental science. His work included studies on the ontogeny of drug metabolizing enzymes, including effects of malnutrition, vitamins, protein intake, and drugs on drug metabolism in the developing fetus and child, bilirubin metabolism, and the excretion of drugs in breast milk. He inspired and mentored countless young pediatric investigators who owe much of their career directions to his teaching.

In 1980, Dr. Yaffe took the position as Director of the Center for Research for Mothers and Children at the National Institute of Child Health and Human Development. During his 20 years at NICHD, Dr. Yaffe’s vision for improved pharmacotherapy for children came to fruition. He tirelessly pursued an agenda for increased research in diseases of childhood. He fostered the development of research networks including a neonatal and fetal/maternal medicine network, and most crucial to pediatric and developmental pharmacology, the Pediatric Pharmacology Research Units. The PPRUs have been the key to advancement of pediatric pharmacology research, and through Dr. Yaffe’s enormous efforts, have received increased funding and have grown from 6 to 13 units. The network includes outstanding young investigators studying basic mechanisms of developmental biology, ontogeny of drug metabolism, and joint clinical studies of a wide variety of therapeutic agents. Collaborative studies among the members of the PPRUs are every day generating new knowledge about how most effectively and safely to use new medicines to treat children in need. Even after his formal retirement from NICHD, Dr. Yaffe continues to mentor the PPRU network, and has focused his energies extensively on internationally cooperation and collaboration of pediatric investigators throughout the world.

Dr. Yaffe’s vision of improved therapy for sick children is becoming a reality. He has inspired an entire generation of pediatric clinical pharmacologists to grow the field into a mature and evolving scientific discipline.

 

Previous Yaffe Award Recipients

Sumner Yaffe

2002

Sumner Yaffe, MD

Lecture Paper

Miles Weinberger

2003

Miles Weinberger, MD

Lecture Paper

William Evans

2004

William Evans, PharmD

Lecture Paper

George McCracken

2005

George McCracken, MD

Lecture Paper

Cheston Berlin

2006

Cheston Berlin, MD

Lecture Paper

Leslie Hendeles

2007

Leslie Hendeles, PharmD

Lecture Paper

Gregory Kearns

2008

Gregory Kearns, PharmD

Lecture Paper

Stephen Spielberg

2009

Stephen Spielberg, MD

Lecture Paper

Michael Reed

2010

Michael Reed, PharmD

Lecture Paper

Mary Relling

2011

Mary Relling, PharmD

Lecture Paper

Gideon Koren

2012

Gideon Koren, MD

Lecture Paper

Milap Nahata

2013

Milap Nahata, PharmD, FPPAG

Lecture Paper

Gilbert Burckart

2014

Gilbert Burckart, PharmD, FPPAG

Lecture Paper

James Cloyd

2015

James Cloyd, PharmD

Lecture Paper

Stan Szefler

2016

Stan Szefler, MD

Lecture Paper

Michael Rieder

2017

Michael Rieder, MD, PhD

Lecture Paper

George Giacoia

2018

George Giacoia, MD

Lecture Paper

John van den Anker

2019

John van den Anker, MD, PhD

Lecture Paper

J. Steven Leeder

2020

J. Steven Leeder, PharmD, PhD

Lecture Paper

Edmund Caparelli

2021

Edmund Caparelli, PharmD

Lecture Paper

Robert Ward

2022

Robert Ward, MD, FAAP, FCP, DABCP

Lecture Paper

Kathryn Blake

2023

Kathryn Blake, PharmD, BCPS, FCCP

Lecture Paper

Anne Zajicek

2024

Anne Zajicek, MD, PharmD, FAAP

Lecture Paper

Alexander A. Vinks

2025

Alexander A. Vinks, PhD., PharmD

Lecture Paper